Among females who decline or defer surgery, early detection options for female carriers of a disease-causing BRCA1/2 variant usually comprise of a combination of routine mammograms and breast MRIs for breast cancer risks, which are effective at detecting breast cancer among BRCA1/2-positive females. The gene discussed is BRCA1; the disease is breast carcinoma.